Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion type Assertion NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_head.
- NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion wasGeneratedBy ECO_0000203 NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_provenance.
- NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion wasDerivedFrom befree-2016 NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_provenance.
- NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion SIO_000772 18182569 NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_provenance.
- NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion evidence source_evidence_literature NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_provenance.
- NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_assertion description "[After adjusting for known prognostic features such as presence of the TEL-AML1 rearrangement, National Cancer Institute (NCI) risk status, ploidy, and race, the G allele of a common polymorphism in chemokine receptor 5 (CCR5) was associated with more favorable MRD status than the A allele (P = .009, logistic regression), when comparing best and worst risk groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP649011.RAh59D4jfzpkTjFlX4Fi6_jKrFf430vnvm4G-jrBCJGEQ130_provenance.